Thromb Haemost 1983; 50(03): 749-752
DOI: 10.1055/s-0038-1665301
Original Article
Schattauer GmbH Stuttgart

A Plasma Factor Enhances Activity of Vitamin K-Dependent Coagulation Proteins

Michael R Owens
The Department of Medicine, University of Rochester School of Medicine, Rochester, New York, U.S.A.
,
Catherine D Cimino
The Department of Medicine, University of Rochester School of Medicine, Rochester, New York, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 17 February 1983

Accepted 31 May 1983

Publication Date:
18 July 2018 (online)

Summary

A plasma factor, “coagulopoietin”, present in animals with depleted vitamin K-dependent coagulation factors, appears to enhance activity of these factors in normal animals. We have investigated the effects of “coagulopoietin” on synthesis of certain coagulation proteins by the isolated rat liver perfused for eight hours. Liver donor rats received plasma injections from vitamin K-deficient rats or from normal rats 24 hr before sacrifice. Coagulation activity of Factor VII and Factor II in liver perfusate samples was measured with a coagulation assay; Factor II synthesis was also measured by rocket immunoelectrophoresis and by activation with E. carinatus venom. Cumulative hepatic synthesis of. Factor VII coagulation activity was increased by 43% when rat liver donors received vitamin K-deficient rat plasma compared to normal rat plasma. Cumulative synthesis of Factor II coagulation activity was increased by 51%, but synthesis of the protein measured immunologically or by activation with venom was not affected. The “coagulopoietin” factor in these studies appears to increase measurable coagulation factor activity without increasing total protein synthesis.

 
  • References

  • 1 Dodds WJ, Hoyer LW. Coagulation activities in perfused organs: regulation by addition of animal plasmas. Br J Haematol 1974; 25: 497-509
  • 2 Miller LL, Hanavan HR, Titthasiri N, Chowdhury A. Dominant role of the liver in the biosynthesis of the plasma proteins with special reference to the plasma mucoproteins (seromucoid) ceruloplasmin and fibrinogen. Advances in Chemistry Series, 44 American Chemical Society; 1964. p 17
  • 3 Kessler CM, Bell WR. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits. J Lab Clin Med 1979; 93: 768-782
  • 4 Kessler CM, Bell WR. Stimulation of fibrinogen synthesis: a possible functional role of fibrinogen degradation products. Blood 1980; 55: 40-46
  • 5 Graves BC, Munns TW, Carlisle TL, Grant GA, Strauss AW. Induction of prothrombin synthesis by prothrombin fragments. Proc Natl Acad Sci USA 1981; 78: 4772-4776
  • 6 Karpatkin M, Karpatkin S. Evidence for a humoral agent capable of raising vitamin K-dependent coagulation factors in rabbits. Br J Haematol 1973; 24: 553-562
  • 7 Karpatkin M, Karpatkin S. Humoral factor that specifically regulates prothrombin (Factor II) levels (coagulopoietin-II). Proc Natl Acad Sci USA 1979; 76: 491-493
  • 8 Shah DV, Nyari LJ, Swanson JC, Suttie JW. Effect of a humoral factor on plasma prothrombin and vitamin K-dependent liver carboxylase levels in the rat. Thromb Res 1980; 19: 111-118
  • 9 Owens MR, Cimino CD. The inhibitory effects of sodium salicylate on synthesis of Factor VII by the perfused rat liver. Thromb Res 1980; 18: 839-845
  • 10 Owens MR, Miller LL, Cimino CD. Synthesis of Factor II antigen by the isolated perfused rat liver. Biochim Biophys Acta 1981; 676: 365-372
  • 11 Owens MR, Miller LL. Net biosynthesis of antithrombin III by the isolated rat liver perfused for 12-24 hours. Biochim Biophys Acta 1980; 627: 30-39
  • 12 Owren PA, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 1951; 3: 201-208
  • 13 Ware AG, Seegers WH. Two-stage procedure for the quantitative determination of prothrombin concentration. Am J Clin Path 1949; 19: 471-482
  • 14 Carlisle TL, Shah DV, Schlegel R, Suttie JW. Plasma abnormal prothrombin and microsomal precursor in various species. Proc Soc Exp Biol Med 1975; 148: 140-144
  • 15 Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 29 Suppl (Suppl. 124) 1972; 21-37
  • 16 Snedechor GW, Cochran WG. Statistical Methods. Iowa State Univ Press; 1980. pp 54-59
  • 17 Friedman EW, Karpatkin M, Karpatkin S. Evidence suggesting the regulation of coagulation factor levels in rabbits by a transferable plasma agent. Blood 1976; 48: 949-954
  • 18 Stenflo J. Vitamin K and the biosynthesis of prothrombin. J Biol Chem 1972; 247: 8167-8175
  • 19 Suttie JW, Jackson CM. Prothrombin structure, activation and biosynthesis. Physiol Rev 1970; 57: 1-70
  • 20 Sadowski JA, Esmon CT, Suttie JW. Vitamin K-dependent carboxylase. J Biol Chem 1976; 251: 2770-2776
  • 21 Girardot JM, Delaney R, Johnson BC. Carboxylation, the completion step in prothrombin biosynthesis. Biochem Biophys Res Commun 1974; 59: 1197-1203